HealthRelyvrio ALS Drug Withdrawn by Manufacturer Due to Lack of Efficacy Due to FDA concerns about its efficacy, Relyvrio, an ALS medication, was removed from the market by Amylyx Pharmaceuticals.by Quincy Jon
HealthNeuralink Rival 'Stentrode' Brain Chip Lets Paralyzed Patients Control Computers with Their Minds!by Isaiah Alonzo
FeatureScientist With ALS Dr. Peter Scott-Morgan Set To Become 'World's Very First Full Cyborg'by Athena Chan
HealthNewly Identified ALS Mechanism May Pave Way For Treatment That Can Cure Lou Gehrig’s Diseaseby Allan Adamson
HealthMan Behind Ice Bucket Challenge Faces Financial Hurdles In Fight Against ALSby Alexandra Lozovschi
HealthBrain Implant Helps Paralyzed ALS Patient Communicate With Caregivers Without Assistanceby Rhodi Lee
HealthStem Cell Research May Help ALS Patients, Study Shows Promise But Has Yet to Confirm Benefitsby Katherine Derla
Healthy Living/WellnessFuneral Directors Face Higher Risks Of ALS Due To Formaldehyde Useby Jill Arce